Literature DB >> 23687119

Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.

Smriti M Agrawal1, Jacqueline Williamson, Ritu Sharma, Hania Kebir, Kamala Patel, Alexandre Prat, V Wee Yong.   

Abstract

Inflammatory perivascular cuffs are comprised of leucocytes that accumulate in the perivascular space around post-capillary venules before their infiltration into the parenchyma of the central nervous system. Inflammatory perivascular cuffs are commonly found in the central nervous system of patients with multiple sclerosis and in the animal model experimental autoimmune encephalomyelitis. Leucocytes that accumulate in the perivascular space secrete matrix metalloproteinases that aid their transmigration into the neural parenchyma. We described previously that the upstream inducer of matrix metalloproteinase expression, extracellular matrix metalloproteinase inducer (CD147), was elevated in experimental autoimmune encephalomyelitis, and that its inhibition reduced leucocyte entry into the central nervous system. Here we investigated whether the expression of extracellular matrix metalloproteinase inducer varies with the temporal evolution of lesions in murine experimental autoimmune encephalomyelitis, whether it was uniformly upregulated across multiple sclerosis specimens, and whether it was a feature of inflammatory perivascular cuffs in multiple sclerosis lesions. In experimental autoimmune encephalomyelitis, elevation of extracellular matrix metalloproteinase inducer was correlated with the appearance and persistence of clinical signs of disease. In both murine and human samples, extracellular matrix metalloproteinase inducer was detected on endothelium in healthy and disease states but was dramatically increased in and around inflammatory perivascular cuffs on leucocytes, associated with matrix metalloproteinase expression, and on resident cells including microglia. Leucocyte populations that express extracellular matrix metalloproteinase inducer in multiple sclerosis lesions included CD4+ and CD8+ T lymphocytes, B lymphocytes and monocyte/macrophages. The extra-endothelial expression of extracellular matrix metalloproteinase inducer was a marker of the activity of lesions in multiple sclerosis, being present on leucocyte-containing perivascular cuffs but not in inactive lesions. By using a function-blocking antibody, we implicate extracellular matrix metalloproteinase inducer in the adhesion of leucocytes to endothelial cells and determined that its activity was more crucial on leucocytes than on endothelium in leucocyte-endothelial cell engagement in vitro. Extracellular matrix metalloproteinase inducer activity regulated the level of alpha 4 integrin on leucocytes through a mechanism associated with nuclear factor κB signalling. Blocking extracellular matrix metalloproteinase inducer attenuated the transmigration of monocytes and B lymphocytes across a model of the blood-brain barrier in culture. In summary, we describe the prominence of extracellular matrix metalloproteinase inducer in central nervous system inflammatory perivascular cuffs, emphasize its dual role in matrix metalloproteinase induction and leucocyte adhesion, and highlight the elevation of extracellular matrix metalloproteinase inducer as an orchestrator of the infiltration of leucocytes into the central nervous system parenchyma.

Entities:  

Keywords:  EMMPRIN; metalloproteinases; multiple sclerosis; neuroinflammation; perivascular cuff

Mesh:

Substances:

Year:  2013        PMID: 23687119     DOI: 10.1093/brain/awt093

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

1.  Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis.

Authors:  Deepak Kumar Kaushik; Anindita Bhattacharya; Reza Mirzaei; Khalil S Rawji; Younghee Ahn; Jong M Rho; V Wee Yong
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

Review 2.  Myeloid cells - targets of medication in multiple sclerosis.

Authors:  Manoj K Mishra; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

3.  Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.

Authors:  Erin L Stephenson; Manoj K Mishra; Daniel Moussienko; Nataly Laflamme; Serge Rivest; Chang-Chun Ling; V Wee Yong
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

Review 4.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

Review 5.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

Review 6.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

7.  Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.

Authors:  Deepak K Kaushik; Heather Y F Yong; Jennifer N Hahn; Claudia Silva; Steven Casha; R John Hurlbert; Francois H Jacques; Robert Lisak; Omar Khan; Carolina Ionete; Catherine Larochelle; Alex Prat; Amit Bar-Or; V Wee Yong
Journal:  PLoS One       Date:  2016-10-11       Impact factor: 3.240

8.  Spatiotemporal evolution of venous narrowing in acute MS lesions.

Authors:  Philipp Eisele; Kristina Szabo; Anne Ebert; Wolfgang Brueck; Michael Platten; Achim Gass
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-01-17

9.  Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Authors:  Adham Fani Maleki; Giulia Cisbani; Nataly Laflamme; Paul Prefontaine; Marie-Michele Plante; Joanie Baillargeon; Manu Rangachari; Jean Gosselin; Serge Rivest
Journal:  Neurotherapeutics       Date:  2021-01-21       Impact factor: 7.620

10.  CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape.

Authors:  Yatong Chen; Jing Xu; Xiaodong Wu; Hui Yao; Zhou Yan; Ting Guo; Wenjing Wang; Peixiao Wang; Yu Li; Xiangmin Yang; Hao Li; Huijie Bian; Zhi-Nan Chen
Journal:  Cell Mol Immunol       Date:  2020-11-11       Impact factor: 22.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.